NCI Immunotherapy Fellowship

Co-sponsored by the National Cancer Institute (NCI) of the National Institutes of Health and SITC and made possible in part by an educational grant from EMD Serono

One Year • Application Deadline
February 20, 2017

Conducted at the Center for Cancer Research (CCR) in Bethesda, MD, this program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches, and also to key opinion leaders in the field of clinical immunotherapy.

Eligibility Criteria

  • Able to relocate to Bethesda, MD for the duration of the fellowship
  • Trained in Medical Oncology, Hematology, Pediatric Oncology, Radiation Oncology, or Surgical Oncology
  • Interest in learning about immunotherapy
  • Preference is given to those with an academic interest
  • Open to US and Non-US trained physicians

Benefits

  • Provides opportunities to understand how to design, write, and run clinical trials, how to treat patients, how to manage toxicities, as well as opportunities to work with multiple experimental agents
  • Work with internationally recognized experts in immunotherapy
  • Learn management of immune-related adverse events
  • Develop experience in writing and running immunotherapy clinical trials
  • Develop experience with a wide array of immunotherapy approaches
    • Immune checkpoint inhibitors
    • Adoptive cellular therapy (CAR-T or TCR transgenic approaches)
    • Therapeutic vaccines
    • Immunocytokines
    • Combination immunotherapy approaches
  • Possibilities for attending and presenting at national/international meetings
  • Attend and participate in regularly scheduled NIH immunotherapy conferences
  • Make a difference in the lives of patients with cancer at the largest hospital in the world devoted solely to research
  • Salary is based on applicable laws, regulations, and policies

Application Period Closed February 20